SCHEMBL6296464

SCHEMBL6296464

CCOC(=O)C1=C(C)Nc2n[nH]cc2C1c1ccccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
POLB P06746 1/20 0.56
KDM4E B2RXH2 4/20 0.55
CYP2C9 P11712 3/20 0.55
TBXA2R P21731 3/20 0.55
ADRA1A P35348 3/20 0.55
SLC6A3 Q01959 3/20 0.55
HSD17B10 Q99714 3/20 0.55
CYP3A4 P08684 3/20 0.55
ADORA3 P0DMS8 3/20 0.55
ALDH1A1 P00352 3/20 0.55
MEN1 O00255 2/20 0.55
CYP1A2 P05177 2/20 0.55
CYP2C19 P33261 2/20 0.55
KMT2A Q03164 2/20 0.55
HIF1A Q16665 2/20 0.55
ABCB11 O95342 2/20 0.55
ABCB1 P08183 2/20 0.55
ADRB3 P13945 2/20 0.55
OPRK1 P41145 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6292201 0.89 HTR1A (0.46) TSHRPOLBTBXA2RADRA1ASLC6A3
SCHEMBL6293581 0.89 TBXA2R (0.49) TSHRPOLBKDM4ECYP2C9TBXA2R
SCHEMBL6293653 0.88 KDM4E (0.51) TSHRKDM4ECYP2C9TBXA2RADRA1A
SCHEMBL6293440 0.87 ADORA3 (0.47) TSHRPOLBKDM4ECYP2C9TBXA2R
SCHEMBL6292289 0.87 TBXA2R (0.48) TSHRPOLBKDM4ECYP2C9TBXA2R
SCHEMBL6292316 0.87 TSHR (0.47) TSHRPOLBKDM4ECYP2C9TBXA2R
SCHEMBL6296672 0.87 TSHR (0.47) TSHRPOLBKDM4ECYP2C9TBXA2R
SCHEMBL6293754 0.86 TSHR (0.48) TSHRPOLBKDM4ECYP2C9TBXA2R
SCHEMBL7017903 0.86 ALDH1A1 (0.41) TSHRPOLBKDM4ETBXA2RADRA1A
SCHEMBL6296650 0.85 ACHE (0.58) TSHRKDM4ECYP2C9TBXA2RADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6977262-B2 Dihydropyrazolopyridine compounds and pharmaceutical use thereof MITSUBISHI PHARMA CORPORATION (JP) 2005-12-20 US disclosed
US-20040052822-A1 Dihydropyrazolopyridine compounds and pharmaceutical use thereof MITSUBISHI PHARMA CORPORATION (JP) 2004-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040052822-A1 Dihydropyrazolopyridine compounds and pharmaceutical use thereof GSK3B, GSK3A, PYGB TSHR 4767/4885POLB 3061/4885KDM4E 1992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.